Columbia Chronic Lyme Disease Research Center

Message from the Director, Dr. Fallon:

This is both a disturbing and an exciting time in the world of Lyme disease.  Disturbing because the medical and public health communities have failed to stem the steady increase in the number of cases of Lyme disease over the last 2 decades – with an expansion of over 35% between 2006-2007 alone.  Exciting because advances in medical technology are leading to breakthroughs in how we understand this disease. 

On the diagnostic front, proteomic studies offer the promise of identifying novel antigen markers that may enhance the ability to distinguish active Lyme disease from past infection.  Mass spectrometry-based technologies, developed in response to biowarfare research, enable the rapid screening of fluids from the bodies of ticks or humans for previously unidentified pathogens - pathogens in ticks, for example, other than Borrelia burgdorferi, that may be causing human disease. 

Genomic studies have begun to identify different strains of Borrelia, some of which may be more virulent, and others which may target different organ systems.   Immunologic studies are now identifying different host immune responses to a spirochetal infection.  These responses may be genetically driven, and predispose certain individuals to develop chronic disease, and others to rapidly eradicate the initial infection. 

Imaging studies in animals using immunoflourescent spirochetes now enable direct real-time visualization of the spirochete’s course through the body.  Human neuroimaging studies enable the identification of circuits of the brain particularly affected among patients with chronic symptoms.

Treatment studies in animal models have definitively shown that the Borrelial spirochete is capable of persisting in the animal host – even after aggressive antibiotic therapy.   And treatment studies in humans have identified tentative biomarkers that may serve to guide treatment selection.  These immunologic and neuroimaging biomarkers, if confirmed by additional prospective research,  will provide clinicians with new tools to distinguish those patients who are most likely to benefit from further antibiotics from those patients who would require other non-antibiotic treatment approaches. 

The pace of medical discovery has been accelerated by funding from the National Institutes of Health and by the generous support of private donors – individuals and non-profit charitable organizations.  Without the support of private donors, the novel, pioneering pilot work that might lead to larger NIH-funded grants would never get started.   About 8 years ago, two organizations (Time for Lyme, Inc, and the Lyme Disease Association) committed themselves to provide the cornerstone funds to establish a major new research Center at one of the world’s foremost medical research institutions - Columbia University.  This multi-disciplinary Research Center, formally opened in 2007, is the first in the United States to focus research specifically on the problem of chronic Lyme disease. It brings together experts in neurology, infectious disease, immunology, genetics, neuroimaging, microbiology, neuropsychiatry, pathology, rheumatology, and public health. 

As the number of typical and atypical cases of Lyme disease increases in the United States, so does the number of patients who go on to develop chronic persistent symptoms.  Lives are being profoundly altered by the bite of a single tick. Our Center’s mission is to identify better diagnostic tests, safer and more effective treatments, and clear biomarkers that will guide treatment selection.  The vast intellectual and biotechnological resources at the Columbia University Medical Center will continue to be tapped to achieve our goals, but our researchers will need new funding to initiate new studies.  We encourage you to read the content on our website, send in suggestions for change, participate in a research study, and if able, send a contribution to support Lyme research.  

Brian Fallon, MD
Director, Lyme and Tick-borne Diseases Research Center

1. Mission Statement

The Lyme and Tick-borne Diseases Research Center was established as the first academic research center in the country to focus multidisciplinary research on chronic Lyme disease. In recognition that a growing number of patients experience ongoing or relapsing symptoms after having been treated for Lyme disease and in recognition that diagnostic tests are plagued by both false positive and false negative results and rarely provide definitive information about the presence or absence of active infection, the mission of this center is to focus research on identifying better diagnostic assays, better treatments, and a better pathophysiologic understanding of the mechanisms of symptom persistence so as to enable the development of more effective treatments.

2. Origins

The Lyme and Tick-borne Diseases Research Center at the Columbia University Medical Center was established on April 30, 2007 through a joint effort of Columbia University, Time for Lyme, Inc., and the Lyme Disease Association. Culminating many years of fund-raising efforts, the opening of this Center represents a major achievement by many generous donors who banded together to lead the fight against this rapidly spreading disease. There two charitable organizations recognized that patients with chronic persistent symptoms were not included in most Lyme research studies even though these patients with later stage symptoms were often the most disabled by the illness. These organizations also recognized that progress in medical science only occurs through the support of well-designed research. To that end, these organizations rallied their efforts to establish this Research Center at Columbia University. The establishment of this Center is the first step toward ensuring that leading researchers at one of the foremost academic research centers in the world are given the resources to focus their research efforts on unraveling the mysteries of chronic Lyme disease.

3. Research Team

 

Jenna's Neuro-Lyme disease website

Jenna in Hawaii

       


 Jenna's Video Blog 

 
 
 
 
 

We respect your email privacy

 

Clear Brain Fog

Get the exact doses used in human clinical research for three most important nutrients that support brain function. Two level scoops of Brain Vibrance Supreme powder supply 1500 mg elemental Acetyl-L-Carnitine, 1200 mg elemental GPC, and 300 mg elemental Phosphatidyl Serine

Boost Your Immune System

Ad  

 

BUST BIOFILMS! 

with unique enzymes that expose Lyme bacteria to killing agents for more effective treatment:

Lumbrokinase

Nattokinase

Serrapeptase

 

May You Be Blessed

 Home
 Lyme Disease
 History of LD
 Biology of LD
 Symptom List
 Diagnosis
 Treatment
 Mysterious shapes
 Herxheimer
 Medical Debate
 Insurance
 Social Securilty Disability
 Lab 257
 Neuro-Lyme?
 Neuroborreliosis
 Neuropathic Pain
 Neurophsychiatric Lyme
 Research
 Tulane
 Columbia
 Dr. Coyle at SUNY
 Co-infections
 Protocols
 Dr Lee Cowden
 Marshall Protocol
 Dr. Klinghardt
 Dr. Zhang
 MMS Protocol
 New Salt Protocol
 Buhner Herbal Protocol
 Victoria's Protocol
 HCL Protocol
 Articles
 Violence and Lyme Disease
 Notes From Dr. Fallon
 Review of Neuroborrelliosis
 Psychological Evaluation of Pediatric, Neurologic Lyme Disease
 Lyme Disease is fastest growing disease
 Balance pH
 Links

 

When You Herx:

Pekana Digestive Pack

Pekana Digestive Pack
 We found these the most successful, broad spectrum digestive and intestinal remedies at our Clinic during 30 years of practice. For detoxing, IBS, colitis, Crohn's disease and all sensitive intestinal problems. (Always in conjunction with qualified medical advice.)
CLICK HERE TO ORDER
 
ApplePoly & Salt 
 MOST ECONOMICAL AND POWERFUL ALTERNATIVE PROTOCOL TO COMBAT CHRONIC LYME! 
 Apple Poly for Lyme Protocol 
 More Powerful than Vitamin C and Reduces Belly Fat at the Same Time! 
  Himalayan Salt Capsules for Lyme Protocol 
 Himalayan Salt capsules provide organic salt loaded with the minerals and trace elements your body needs.